Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

MAMMALIAN PHENOTYPE - ANNOTATIONS

The Mouse Adult Gross Anatomy Ontology and Mammalian Phenotype Ontology are downloaded weekly from the Mouse Genome Informatics databases at Jackson Laboratories (ftp://ftp.informatics.jax.org/pub/reports/index.html). For more information about these ontologies, see the MGI Publications Page at http://www.informatics.jax.org/mgihome/other/publications.shtml.

Term:decreased organ/body region tumor incidence
go back to main search page
Accession:MP:0010282 term browser browse the term
Definition:less than the expected number of tumors originating in a specific body region or organ in a given population in a given time period
Synonyms:exact_synonym: decreased organ/body region tumour incidence;   reduced organ/body region tumor incidence;   reduced organ/body region tumour incidence



show annotations for term's descendants           Sort by:
 
decreased hepatoma incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar1 Hepatocarcinoma resistance QTL 1 IDA RGD PMID:10493520 RGD:619598 NCBI chr10:6,154,182...15,990,232 JBrowse link
Q Hcar10 Hepatocarcinoma resistance QTL 10 IDA RGD PMID:12154055 RGD:629566 NCBI chr 8:40,713,066...82,925,667 JBrowse link
Q Hcar11 Hepatocarcinoma resistance QTL 11 IDA RGD PMID:12154055 RGD:629566 NCBI chr 6:82,523,650...110,548,006 JBrowse link
Q Hcar12 Hepatocarcinoma resistance QTL 12 IDA RGD PMID:12154055 RGD:629566 NCBI chr 3:29,463,235...118,376,539 JBrowse link
Q Hcar13 Hepatocarcinoma resistance QTL 13 IDA RGD PMID:15185337 RGD:737884 NCBI chr 4:1...32,584,199 JBrowse link
Q Hcar14 Hepatocarcinoma resistance QTL 14 IDA RGD PMID:15185337 RGD:737884 NCBI chr18:51,464,733...83,218,561 JBrowse link
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:153,136,852...260,522,016 JBrowse link
Q Hcar2 Hepatocarcinoma resistance QTL 2 IDA RGD PMID:10493520 RGD:619598 NCBI chr 4:78,878,504...123,878,504 JBrowse link
Q Hcar3 Hepatocarcinoma resistance QTL 3 IDA RGD PMID:10493520 RGD:619598 NCBI chr 8:54,237,644...99,103,503 JBrowse link
Q Hcar4 Hepatocarcinoma resistance QTL 4 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:193,422,268...214,537,671 JBrowse link
Q Hcar5 Hepatocarcinoma resistance QTL 5 IDA RGD PMID:10850431 RGD:619609 NCBI chr 1:214,537,555...226,660,468 JBrowse link
Q Hcar6 Hepatocarcinoma resistance QTL 6 IDA RGD PMID:10850431 RGD:619609
Q Hcar7 Hepatocarcinoma resistance QTL 7 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:70,808,386...115,808,386 JBrowse link
Q Hcar8 Hepatocarcinoma resistance QTL 8 IDA RGD PMID:10850431 RGD:619609 NCBI chr 4:123,143,783...168,143,783 JBrowse link
Q Hcar9 Hepatocarcinoma resistance QTL 9 IDA RGD PMID:12154055 RGD:629566 NCBI chr 4:109,866,907...167,139,601 JBrowse link
decreased liver tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Hcar15 Hepatocarcinoma resistance QTL 15 IDA RGD PMID:15771619 RGD:1358145 NCBI chr 1:153,136,852...260,522,016 JBrowse link
Q Lnnr1 Liver neoplastic nodule remodeling QTL 1 IDA RGD PMID:12672032 RGD:629574 NCBI chr 7:34,293,282...79,293,282 JBrowse link
Q Lnnr2 Liver neoplastic nodule remodeling QTL 2 IDA RGD PMID:12672032 RGD:629574 NCBI chr 1:233,948,574...260,522,016 JBrowse link
Q Lnnr3 Liver neoplastic nodule remodeling QTL 3 IDA RGD PMID:15185337 RGD:737884 NCBI chr 2:1...41,244,106 JBrowse link
Q Lnnr4 Liver neoplastic nodule remodeling QTL 4 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:1...42,356,786 JBrowse link
Q Lnnr5 Liver neoplastic nodule remodeling QTL 5 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:59,874,408...85,581,182 JBrowse link
Q Lnnr6 Liver neoplastic nodule remodeling QTL 6 IDA RGD PMID:15185337 RGD:737884 NCBI chr13:74,862,117...85,581,182 JBrowse link
decreased mammary gland tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Emca10 Estrogen-induced mammary cancer QTL 10 IDA RGD PMID:18420736 RGD:2292503 NCBI chr 6:16,536,140...61,536,140 JBrowse link
Q Mamtr1 Mammary tumor resistance QTL 1 IAGP RGD PMID:12844486 RGD:631852 NCBI chr 5:12,789,751...113,558,310 JBrowse link
Q Mamtr2 Mammary tumor resistance QTL 2 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:7,887,772...12,654,247 JBrowse link
Q Mamtr3 Mammary tumor resistance QTL 3 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:32,373,770...43,665,178 JBrowse link
Q Mamtr4 Mammary tumor resistance QTL 4 IDA RGD PMID:14522903 RGD:724790 NCBI chr 2:16,491,740...61,491,740 JBrowse link
Q Mcs28 Mammary carcinoma susceptibility QTL 28 IAGP RGD PMID:21205740 RGD:5684388 NCBI chr 5:77,743,239...78,039,084 JBrowse link
decreased tongue tumor incidence term browser
Symbol Object Name Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
Q Tcat1 Tongue tumor resistance QTL 1 QTM RGD PMID:9563479 RGD:61091 NCBI chr 1:99,267,916...144,267,916 JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  mammalian phenotype 5368
    neoplasm 243
      abnormal tumor susceptibility 236
        abnormal tumor incidence 225
          abnormal organ/body region tumor incidence 189
            decreased organ/body region tumor incidence 51
              decreased alimentary system tumor incidence + 2
              decreased cardiovascular system tumor incidence 0
              decreased eye tumor incidence 0
              decreased gland tumor incidence + 26
              decreased hemolymphoid system tumor incidence + 0
              decreased hepatobiliary system tumor incidence + 23
              decreased integument system tumor incidence + 26
              decreased lung tumor incidence 0
              decreased muscle tumor incidence + 0
              decreased nervous system tumor incidence 0
              decreased reproductive system tumor incidence + 0
              decreased respiratory system tumor incidence 0
              decreased reticular tumor incidence + 0
              decreased skeletal tumor incidence + 0
              decreased urinary system tumor incidence 0
paths to the root